$TNTY breaches lower bolliesThe candles breached the lower bollie yesterday by more than 50% signaling a 85% likelyhood for a correction with the MACD and STO supporting my idea.
Pharmaceuticals
TEVA H&S formation - price preparing to turnThe $TEVA chart just keeps getting better and better....
Quarterly chart is rejecting last 2 major lows with a pinbar with stoch RSI overbought
Ideally we bounce here to retest the fibs and form a right shoulder before complete capitulation.
If the H&S formation is confirmed $TEVA should head down to levels we haven't seen since the 90's ($10 and below)
mid term long on TRVNentry 4.00, exit 5.00
looks oversold, the study results were luke warm, but positive.
Possible H&S within TEVA?We appear to be bottoming at the neckline of a potential H&S. This thing is a monster and can be easily seen on the 6 month and yearly time frames.
You could buy the relief rally that takes us back up or wait for extra confirmation and sell the relief rally with a formation of that shoulder.
Possible double top @ 0.02415/10/5 minute charts show double top @ 0.024.
Going to hold this one but could be an indicator that we are going down.
GILD Long, Bargain Price, Monthly MACD Looks BeautifulIf you check the ideas I´ve posted, you can see the monthly GILD chart, were you can clearly see the stock is about to blow up and at a great entry price.
Right here you can see how the stock made 3 resistance levels, a few weeks ago it validated the second resistance and it just did with the first one.
Enter now or regret it later.
Go big or go home.
GILD Long Due to Rebound, Cheap Prince, Indicators in LineI consider GILD to be a great investment because of various factors:
Talking fundamentaly, the company has great numbers and a lot of room to expand.
It's free cash flow is stunning and the company is way to big to be bought.
Technicaly:
As you can see, the MACD, RSI and Stochastic are in line, and ready to go up up up.
P/E is at a beautiful 6.95.
As you can see in the weekly chart, it's just about to go up.
I found a good entry point anywhere between 72 and 73 dolars a share due to support levels.
GO BIG OR GO HOME.
(TEVA)-Entering buy zoneNo position yet. Refer to chart:)
If you have any thoughts about this company, please leave in the comments:)
$KBIO Long12.5.2016- $KBIO currently trading at 4.25. Potential once they receive PRV (Priority Review Voucher) for Benznidazole possibility for trading at $5-6. Stock jumped about $1 due to the Letter to Stakeholders by Dr. Cameron Durrant. I expect this stock to rise.
Disclosure: I am long $KBIO
SEE MORE: globenewswire.com
LLY Eli Lilly: Where can we buy?This stock has been in a correction for about a year now and it looks like it is not done yet. Looking to the price history on the left we can see that we could soon hit strong support starting from $60.00 which is basically the top of a $48-60 price channel. So I would be looking to buy anywhere below $60 if we re-enter that channel (yellow box). I don't expect price to just move through this channel, just like we cannot just break through a herd of cows crossing the street while driving. In addition, if we copy the move from the swing highs to swing lows from 2015-2016 we can see that an equal move would end right around $60 as well, providing a further reason for entry.
More downside for INCYAfter a huge run, Incyte Pharmaceuticals is tired and this flag suggest more downside to come.
LONG LONG ProShares UltraShort Nasdaq Biotechnology ETF (BIS)ProShares UltraShort Nasdaq Biotechnology ETF BIS has already build up its base line or support you can say. It is the only stock (ZBIO, LABD) where the price line has clearly shows the support over the last one year period of time from July 2015 till Aug 2016. Slowly but gradually it's going NORTH. Time to buy for long time holders.
www.zacks.com
LABD Direxion Daily S&P Biotech Bear 3x Shares As soon as the red solid channel breaks. it's time to party.
www.zacks.com
ZBIO ProShares UltraProShort Nasdaq BiotechnologyIt's a buy those who doesn't like to go short IBB
www.zacks.com
:) PFIZER TOPPED OUT :0GO HSORT GUYS WITH LEAP OPTIONS OF NEEDED.
PFIZER TOPPED OUT.
buy the rumor sell the news " Pfizer to Buy Medivation for $14 Billion" The bigger the buy the greater the fall.
www.wsj.com
PFIZER is trying her last bet to survive but eventually will fall. wish Pfizer CEO and all the board directors can see it for them to look for new job or polish up resume or start networking before it gets worse.
From 199 high the RED line is touching to new high. As soon as it breaks the light solid (not the dotted one) Green line it will fll pretty hard even though there will be a short term bounce from belwo solid green line but eventually if you hold you short from now on you will be a gainer for coming years. But question is do you have the patience or the risk appetite. Enjoy your lunch guys.
$TKAI Lovely Pharma StockBounced from 1.01 52wk lows,
Now showing support @1.18
Shorts seems to cover,
Next Leg Up, EVOK type of gap to fill.
NASDAQ:TKAI
Acasti's stocksProblems were of course apparent in 2015, but to examine Acasti's downfall, you can look as far back as 2013 where the company took a huge plunge.
Horizontal Horizontal movement this stock looks good for swing and position trades. Or as an option trade straddles and strangles. However one interesting aspect is that the OBV is in a trend upward, precluding an long run trend.
CIPLA LONGExtremely favourable risk reward trade. Stoploss at 503, just above 200 week moving average. Extremely important level for any stock. It has broken the resistance level of 500 and may soon breach 100 DMA.
First target is 540 and second target is 576.
This trade does derive comfort from the general breakout of pharma sector in India.
$ARNA, $1.50 on the menu... Again!Stock insanely undervalued with Belviq and a great board! Biotechs tend to perform well in bear markets.
I will create a google drive for company models, so that everyone has access.
1.50 is a great price to buy more if you are already in this
GL
www.tradingsignalreviews.com
Healthcare,biotech, pharmaceuticals stocks looking AttractiveMoney flow is at the lowest point of 2016 attract
CIPLA - "BUY" Medicine on reports As per Elliot Wave, 5 wave correction has been completed at 580 levels and now I expect to see 3 corrective waves before it continues on to its downtrend. Markets in all indices show similar charts, and I believe the markets are ready for a short term corrective upward move.
Risk Reward: 1:5
Target 1: 609-620
Stop Loss:570
